Representative before the EPO

Company dna celltech r and d limited
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 6 EP applications John Thompson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11779451

PROCESS FOR PREPARING LACOSAMIDE

IPC classification:
C07C 233/47, C07C 229/22, C07C 237/22
Applicant:
UCB Pharma GmbH
Agent:
Frank Dressen, UCB Pharma GmbH
Agent:
John Thompson, UCB Celltech
Status:
GRANT OF PATENT INTENDED
EP12756727

AUTOIMMUNE AND INFLAMMATORY DISORDER THERAPY

IPC classification:
G01N 33/564
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP12801466

THERAPEUTICALLY ACTIVE THIAZOLO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, C07D 513/04, A61P 37/00, A61P 35/00, A61P 31/00, A61P 29/00
Applicant:
UCB Biopharma SPRL
Applicant:
UCB Pharma S.A.
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
PATENT GRANTED
EP13776992

THERAPEUTICALLY ACTIVE OXAZOLINE DERIVATIVES

IPC classification:
A61K 31/519, C07D 495/04, A61P 29/00
Applicant:
UCB Biopharma SPRL
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
The patent has been granted
EP15162142

Purine analogues and their use as immunosuppressive agents

IPC classification:
A61K 31/519, C07D 513/04, A61P 29/00
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
The patent has been granted
EP13814962

THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, C07D 487/04, A61P 35/00
Applicant:
UCB Biopharma SPRL
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
The patent has been granted

Please Sign in to use this feature